Stephen M Ksenak's most recent trade in AMBAC Financial Group Inc. was a trade of 32,097 Restricted Stock Units done . Disclosure was reported to the exchange on July 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 32,097 | 46,151 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 4,726 | 14,054 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 4,726 | 123,302 (0%) | 0% | 0 | Common Stock | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.39 per share. | 13 Mar 2025 | 1,703 | 121,599 (0%) | 0% | 8.4 | 14,288 | Common Stock |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 53,999 | 129,146 | - | - | Deferred Share Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 1,967 | 118,576 (0%) | 0% | 0 | Common Stock | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.16 per share. | 06 Mar 2025 | 1,967 | 118,576 (0%) | 0% | 9.2 | 18,018 | Common Stock |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 5,051 | 23,381 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 4,601 | 18,780 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 4,469 | 70,946 | - | - | Deferred Share Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 4,201 | 75,147 | - | - | Deferred Share Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 582 | 117,191 (0%) | 0% | - | Common Stock | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.71 per share. | 28 Feb 2025 | 582 | 116,609 (0%) | 0% | 9.7 | 5,651 | Common Stock |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 400 | 117,009 (0%) | 0% | - | Common Stock | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.30 per share. | 28 Feb 2025 | 400 | 116,609 (0%) | 0% | 9.3 | 3,720 | Common Stock |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Purchase of securities on an exchange or from another person at price $ 11.00 per share. | 07 Aug 2024 | 5,000 | 116,609 (0%) | 0% | 11 | 55,000 | Common Stock |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 14,179 | 28,432 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 5,959 | 66,477 | - | - | Deferred Share Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 5,959 | 14,253 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.38 per share. | 08 Mar 2024 | 218 | 111,609 (0%) | 0% | 15.4 | 3,353 | Common Stock |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 218 | 20,212 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 218 | 111,827 (0%) | 0% | 0 | Common Stock | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2024 | 4,438 | 60,518 | - | - | Deferred Share Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 4,438 | 20,430 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.19 per share. | 03 Mar 2024 | 163 | 111,609 (0%) | 0% | 16.2 | 2,639 | Common Stock |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 163 | 24,868 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 163 | 111,772 (0%) | 0% | 0 | Common Stock | |
| AMBAC Financial Group Inc. | Ksenak Stephen M. | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 4,872 | 56,080 | - | - | Deferred Share Units | |
| AMBAC Financial Group Inc. | M. Ksenak Stephen | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 4,872 | 25,031 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 178 | 29,903 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | M. Ksenak Stephen | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.94 per share. | 28 Feb 2024 | 178 | 111,609 (0%) | 0% | 16.9 | 3,015 | Common Stock |
| AMBAC Financial Group Inc. | Stephen Ksenak M. | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 178 | 111,787 (0%) | 0% | 0 | Common Stock | |
| AMBAC Financial Group Inc. | M. Stephen Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 40,442 | 51,208 | - | - | Deferred Share Units | |
| AMBAC Financial Group Inc. | Ksenak Stephen M. | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2024 | 1,861 | 113,470 (0%) | 0% | 0 | Common Stock | |
| AMBAC Financial Group Inc. | M. Stephen Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.25 per share. | 21 Feb 2024 | 1,861 | 111,609 (0%) | 0% | 16.2 | 30,241 | Common Stock |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 5,894 | 10,766 | - | - | Deferred Share Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 5,894 | 30,081 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 282 | 111,891 (0%) | 0% | 0 | Common Stock | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 282 | 35,975 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.41 per share. | 08 Mar 2023 | 282 | 111,609 (0%) | 0% | 16.4 | 4,628 | Common Stock |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 13,803 | 36,257 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 4,872 | 4,872 | - | - | Deferred Share Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 4,872 | 22,454 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 178 | 111,787 (0%) | 0% | 0 | Common Stock | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 178 | 27,326 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.55 per share. | 28 Feb 2023 | 178 | 111,609 (0%) | 0% | 16.6 | 2,946 | Common Stock |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2023 | 36,351 | 130,215 (0%) | 0% | 0 | Common Stock | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.22 per share. | 22 Feb 2023 | 18,606 | 111,609 (0%) | 0% | 16.2 | 301,789 | Common Stock |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2023 | 2,778 | 27,504 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2023 | 2,778 | 95,443 (0%) | 0% | 0 | Common Stock | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.44 per share. | 02 Jan 2023 | 1,579 | 93,864 (0%) | 0% | 17.4 | 27,538 | Common Stock |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 6,177 | 95,818 (0%) | 0% | 0 | Common Stock | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 6,177 | 30,282 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.85 per share. | 08 Mar 2022 | 3,153 | 92,665 (0%) | 0% | 12.8 | 40,516 | Common Stock |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 15,151 | 36,459 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2022 | 19,124 | 99,384 (0%) | 0% | 0 | Common Stock | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.35 per share. | 24 Feb 2022 | 9,743 | 89,641 (0%) | 0% | 14.3 | 139,812 | Common Stock |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2022 | 4,965 | 83,083 (0%) | 0% | 0 | Common Stock | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2022 | 4,965 | 21,308 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.05 per share. | 02 Jan 2022 | 2,823 | 80,260 (0%) | 0% | 16.0 | 45,309 | Common Stock |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 18,530 | 26,273 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2021 | 2,389 | 79,202 (0%) | 0% | 0 | Common Stock | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2021 | 2,389 | 0 | - | - | Deferred Share Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.93 per share. | 04 Mar 2021 | 1,084 | 78,118 (0%) | 0% | 16.9 | 18,352 | Common Stock |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 28,716 | 90,152 (0%) | 0% | 0 | Common Stock | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.39 per share. | 01 Mar 2021 | 14,591 | 75,561 (0%) | 0% | 17.4 | 253,737 | Common Stock |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 2,393 | 7,743 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 2,393 | 77,954 (0%) | 0% | 0 | Common Stock | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.77 per share. | 01 Mar 2021 | 1,141 | 76,813 (0%) | 0% | 16.8 | 19,135 | Common Stock |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2021 | 4,966 | 10,136 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2021 | 4,966 | 64,112 (0%) | 0% | 0 | Common Stock | |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.38 per share. | 02 Jan 2021 | 2,676 | 61,436 (0%) | 0% | 15.4 | 41,157 | Common Stock |